Clover Initiates Phase 2 Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates admin 2 hours ago South Tv Comments Off on Clover Initiates Phase 2 Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates 0 Views PressBee – — Phase 2 Initiation Strengthens Global First-in-Class Potential for Clover’s Protein-Based RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates – Share Facebook Twitter Stumbleupon LinkedIn Pinterest
